Clinical Trial Update: Hepatocellular Carcinoma (HCC)_Torisel_ [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial of temsirolimus (Torisel) in inoperable hepatocellular carcinoma conducted by the Chinese University of Hong Kong.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Torisel (Temsirolimus)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Inoperable HCC | Phase 1, Phase 2 | Status: COMPLETED